-
EntrepreneurAddimmune Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
-
EntrepreneurCreative BioTherapeutics WE START WHERE OTHER THERAPIES FAIL FOR RECURRENT & DRUG RESISTANT CANCERS
-
EntrepreneurGel Dynamics A Vetted Solution With A Global Market
-
EntrepreneurVIC Tech A LIFE SCIENCE VENTURE STUDIO - Building a Healthy Future
-
EntrepreneurGreentech Laboratories ADVANCING HUMAN LIFE WITH TECHNOLOGIES FOR INNER WELLBEING
-
EntrepreneurKurve Therapeutics The Future of Systemic and Central Nervous System (CNS) Therapies - Bringing solutions to clinical unmet needs
-
EntrepreneurCommerceBlitz Optimizing Inventory and Distribution Operations for eCommerce Businesses
-
EntrepreneurTitin KM Biomedical Corporation THE FUTURE OF SHOULDER REHABILITATION
-
EntrepreneurTracFlo A vertical SaaS Fintech focused on construction
-
EntrepreneurMedAware Transforming patient safety
-
Information
iCFO Information Booth How can we help? -
Entrepreneur
Nob Hill Therapeutics Pioneering Respiratory Patient Care
-
Entrepreneur
PROOF Hard Ice Cream PROOF will be among the most highly recommended gourmet brands in the world
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Eli Thomssen!
Join us next time to meet Eli Thomssen!
About Adlore
Adlore
Introducing SenLore - A Novel Device to Treat and Monitor Diabetic Foot Ulcers
Available from
12:00 PM
-
4:00 PM
(US/Pacific)
+1 269-491-6431
Adlore, Inc® was founded to develop SenLoreTM, a smart boot to treat and monitor diabetic foot ulcers (DFUs) at home or in an extend nursing facility. SenLore will be a therapeutic boot device to accelerate wound healing by combining controlled heat and electrical stimulation (ES) to increase blood flow to the wound site and feedback sensors to monitor performance for remote patient monitoring.
